|
|
N/A
|
15K
$0
|
|
|
|
N/A
|
8.03K
$0
|
|
|
|
N/A
|
13.3K
$0
|
|
|
|
N/A
|
22.8K
$0
|
|
|
|
N/A
|
14.3K
$0
|
|
|
|
N/A
|
14.1K
$0
|
|
|
|
N/A
|
12.4K
$0
|
|
|
|
N/A
|
10.8K
$0
|
|
|
|
N/A
|
1.56M
$0
|
|
Invesco Actively Managed Exc
|
|
N/A
|
37.3K
$0
|
|
Invesco Exch Traded Fd Tr Ii
|
|
N/A
|
8.73K
$0
|
|
Invesco Exch Trd Slf Idx Fd
|
|
N/A
|
103K
$0
|
|
|
|
N/A
|
36.3K
$0
|
|
Invesco Exchange Traded Fd T
|
|
N/A
|
26.9K
$0
|
|
|
|
N/A
|
13.4K
$0
|
|
|
|
N/A
|
23.3K
$0
|
|
|
|
N/A
|
16.9K
$0
|
|
|
|
N/A
|
69.9K
$0
|
|
|
|
N/A
|
28.7K
$0
|
|
Investment Managers Ser Tr I
|
|
N/A
|
28.7K
$0
|
|
|
|
N/A
|
2.32M
$0
|
|
|
|
N/A
|
11.6K
$0
|
|
|
|
N/A
|
48.6K
$0
|
|
|
|
N/A
|
20.8K
$0
|
|
|
|
N/A
|
89K
$0
|
|
|
|
N/A
|
109K
$0
|
|
|
|
N/A
|
31.4K
$0
|
|
|
|
N/A
|
133K
$0
|
|
|
|
N/A
|
42.6K
$0
|
|
|
|
N/A
|
24.3K
$0
|
|
|
|
N/A
|
8.66K
$0
|
|
|
|
N/A
|
17.2K
$0
|
|
|
|
N/A
|
12.9K
$0
|
|
|
|
N/A
|
53.2K
$0
|
|
|
|
N/A
|
41.8K
$0
|
|
|
|
N/A
|
32.6K
$0
|
|
|
|
N/A
|
107K
$0
|
|
|
|
N/A
|
26.7K
$0
|
|
J P Morgan Exchange Traded F
|
|
N/A
|
23.6K
$0
|
|
J P Morgan Exchange Traded F
|
|
N/A
|
41.1K
$0
|
|
J P Morgan Exchange Traded F
|
|
N/A
|
8.67K
$0
|
|
|
|
N/A
|
410K
$0
|
|
Kandi Technologies Group Inc
|
|
N/A
|
85.9K
$0
|
|
|
|
N/A
|
27.9K
$0
|
|
|
|
N/A
|
34.4K
$0
|
|
Kestra Med Technologies LTD
|
|
N/A
|
1.51M
$0
|
|
Kiniksa Pharmaceuticals Intl
|
|
N/A
|
267K
$0
|
|
|
|
N/A
|
35.5K
$0
|
|
|
|
N/A
|
351K
$0
|
|
|
|
N/A
|
140K
$0
|
|